 SEATTLE, Oct. 14, 2022 GLOBE NEWSWIRE -- Chinook Therapeutics, Inc. Nasdaq: KDNY, a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced nine abstracts to be presented at ASN Kidney Week 2022 from November 3 6, 2022 in Orlando, Florida. Five abstracts will be presented as posters, one abstract will be delivered as an oral presentation and three abstracts will be presented as informational posters. 